Do patient access schemes for high-cost cancer drugs deliver value to society?—lessons from the NHS Cancer Drugs Fund

por Aggarwal, A., Fojo, T., Chamberlain, C., Davis, C., Sullivan, R.
Publicado 2017

Perceptions of intermittent preventive treatment of malaria in pregnancy (IPTp) and barriers to adherence in Nasarawa and Cross River States in Nigeria

por Diala, Chamberlain C, Pennas, Thaddeus, Marin, Celeste, Belay, Kassahun A
Publicado 2013

Does the cancer drugs fund lead to faster uptake of cost-effective drugs? A time-trend analysis comparing England and Wales

por Chamberlain, C, Collin, S M, Stephens, P, Donovan, J, Bahl, A, Hollingworth, W
Publicado 2014

P112: ENERGIZE AND ENERGIZE-T: TWO PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDIES OF MITAPIVAT IN ADULTS WITH NON--TRANSFUSION-DEPENDENT OR TRANSFUSION-DEPENDENT ALP...

por Kuo, K, Layton, D, Al-Samkari, H, Kattamis, A, Sheth, S, Taher, A, Viprakasit, V, Chamberlain, C, Czapla, L, Gheuens, S, Lynch, M, Tong, B, Uhlig, K, Cappellini, M
Publicado 2022